Literature DB >> 19233758

Cardioprotective effects of sevoflurane, isoflurane, and propofol in coronary surgery patients: a randomized controlled study.

Vedat Yildirim1, Suat Doganci, Ahmet Aydin, Cengiz Bolcal, Ufuk Demirkilic, Ahmet Cosar.   

Abstract

BACKGROUND: This study was undertaken to compare the in vivo effects of isoflurane, sevoflurane, and propofol anesthesia on ischemia- and reperfusion-mediated free-radical injury and oxidative stress during coronary artery bypass graft surgery. We also compared the effects of these anesthetic agents on levels of end products of lipid peroxidation and nitric oxide (NO) in human right atrial tissue and blood.
METHODS: Sixty patients scheduled to undergo elective coronary surgery with cardiopulmonary bypass (CPB) were enrolled. Patients were randomly allocated to receive 1 of 3 different anesthetic protocols: propofol (group A), isoflurane (group B), or sevoflurane (group C). We recorded global hemodynamic data (mean arterial pressure, mean pulmonary artery pressure, central venous pressure, pulmonary capillary wedge pressure, cardiac output, cardiac index, and systemic vascular resistance index) just before the start of surgery, before the start of CPB, 15 minutes after the end of CPB, at the end of the operation, 6 hours after installation in the intensive care unit, and 12 and 24 hours later. Samples of the right atrial appendage were harvested before and after exposure of the heart to blood cardioplegia and short-term reperfusion under conditions of CPB. Biochemical and oxidative stress parameters were analyzed in both blood and tissue.
RESULTS: Hemodynamic parameters were kept stable throughout in all groups. Troponin I increased transiently with all used anesthetic regimens, but this increase was significantly lower in groups B and C. After clamp removal, lipid peroxidation in patients who received propofol (group A) was less than in patients who received isoflurane (group B) or sevoflurane (group C) (P= .001, P= .005, respectively). Although the 3 groups showed no statistically significant differences in tissue levels of thiobarbituric acid-reactive substances and superoxide dismutase, propofol significantly lowered NO production in atrial tissue after clamp removal and induced less NO production than sevoflurane (P< .05).
CONCLUSION: Inhalation anesthetics such as isoflurane and sevoflurane preserved cardiac function in coronary surgery patients after CPB with less evidence for myocardial damage than propofol. Furthermore, propofol induced lower blood levels of lipid peroxidation than isoflurane and sevoflurane. Propofol also increased glutathione peroxidase activity but induced less NO production compared to sevoflurane. These findings also support the cardioprotective properties that are demonstrated by hemodynamic parameters.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233758     DOI: 10.1532/HSF98.20081137

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  9 in total

1.  Propofol administration to the fetal-maternal unit reduces cardiac oxidative stress in preterm lambs subjected to prenatal asphyxia and cardiac arrest.

Authors:  Matthias Seehase; Patrick Houthuizen; Jennifer J P Collins; Luc J Zimmermann; Boris W Kramer
Journal:  Pediatr Res       Date:  2016-01-13       Impact factor: 3.756

2.  Meta-analysis of the cardioprotective effect of sevoflurane versus propofol during cardiac surgery.

Authors:  Feng Li; Yuan Yuan
Journal:  BMC Anesthesiol       Date:  2015-09-24       Impact factor: 2.217

3.  Effects of sevoflurane pretreatment on the apoptosis of rat H9c2 cardiomyocytes and the expression of GRP78.

Authors:  Zhongli Wang; Rongsheng Cui; Kai Wang
Journal:  Exp Ther Med       Date:  2018-01-25       Impact factor: 2.447

4.  Receptor for activated C kinase 1 in rats with ischemia-reperfusion injury: intravenous versus inhalation anaesthetic agents.

Authors:  Eun-Hye Seo; Ga-Yun Song; Ji Hyeon Namgung; Chung-Sik Oh; Seung Hyun Lee; Seong-Hyop Kim
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

Review 5.  The Impact of Volatile Anesthetic Choice on Postoperative Outcomes of Cardiac Surgery: A Meta-Analysis.

Authors:  Andres Zorrilla-Vaca; Rafael A Núñez-Patiño; Valentina Torres; Yudy Salazar-Gomez
Journal:  Biomed Res Int       Date:  2017-08-29       Impact factor: 3.411

6.  Increased Hemoglobin Oxygen Affinity With 5-Hydroxymethylfurfural Supports Cardiac Function During Severe Hypoxia.

Authors:  Alfredo Lucas; Eilleen S Y Ao-Ieong; Alexander T Williams; Vivek P Jani; Cynthia R Muller; Ozlem Yalcin; Pedro Cabrales
Journal:  Front Physiol       Date:  2019-10-30       Impact factor: 4.566

7.  Safety and Feasibility of AnaConDa™ to Deliver Inhaled Isoflurane for Sedation in Patients Undergoing Elective Postoperative Mechanical Ventilation: A Prospective, Open-label, Interventional Trial (INSTINCT I Study).

Authors:  Atul Prabhakar Kulkarni; Shilpushp Jagannath Bhosale; Kushal Rajeev Kalvit; Tarun Kumar Sahu; Rakesh Mohanty; Meshach M Dhas; Gautam Gondal; Swapna Charie; Anjana Shrivastava; Jigeeshu V Divatia
Journal:  Indian J Crit Care Med       Date:  2022-08

8.  Additive Effect on Survival of Anaesthetic Cardiac Protection and Remote Ischemic Preconditioning in Cardiac Surgery: A Bayesian Network Meta-Analysis of Randomized Trials.

Authors:  Alberto Zangrillo; Mario Musu; Teresa Greco; Ambra Licia Di Prima; Andrea Matteazzi; Valentina Testa; Pasquale Nardelli; Daniela Febres; Fabrizio Monaco; Maria Grazia Calabrò; Jun Ma; Gabriele Finco; Giovanni Landoni
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 9.  Comparing cardiac troponin levels using sevoflurane and isoflurane in patients undergoing cardiac surgery: a systematic review and meta-analysis.

Authors:  Hossein Hosseinifard; Nashmil Ghadimi; Sara Kaveh; Hossein Shabaninejad; Alaadine Lijassi; Rasoul Azarfarin
Journal:  J Cardiovasc Thorac Res       Date:  2020-02-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.